BHR Pharmaceuticals logo link to Home Page
 
 
 
 
 
 
 
 
   
   
   
   
Actim

Medix Biochemica in Finland are pioneers in the world of monoclonal antibodies, and has developed these tests after extensive research. They have proven to be extremely reliable and help the physician make critical decisions in the treating of his/her patient

ActimPARTUS – helps determine cervical ripeness Helps you determine the risk of preterm delivery. In many cases it is essential to determine whether an expectant mother is merely experiencing normal preterm contractions or whether she is indeed in true labour.

ActimPROM – detects premature rupture of the membranes This test reliably detects premature rupture of foetal membranes (PROM). Since PROM accounts for approximately 10% of all prenatal deaths, truly reliable diagnosis is essential to ensure the well-being of both mother and child. Even micro ruptures need to be detected, since they predispose both foetus and mother to infections.

ActimFECALBLOOD- gives an early warning sign of bowel diseases Colorectal cancer affects men and women equally and is one of the most common types of cancer. Occult blood in faecal samples is a sign of bleeding in the gastrointestinal tract. As tumours bleed, the presence of occult blood may therefore indicate colorectal cancer. The test is easy and hygienic to use, and since it is specific for human haemoglobin it requires no dietary restrictions on the patient. The sensitivity of the test is set to detect patients who have more than 25-50 µg of haemoglobin per gram of faeces and may therefore need to be referred for subsequent endoscopic examinations.

ActimPANCREATITIS – a reliable and sensitive test for acute pancreatitis Acute pancreatitis is a serious disease in which 20-30% of patients may develop severe pancreatitis with a mortality rate of up to 40%. Since treatment is more likely to succeed if initiated early, rapid diagnosis of acute pancreatitis is vital.

ActimPANCREATITIS is an immunochromatographic dipstick test based on monoclonal antibodies detecting trypsinogen-2 in urine. Trypsinogen-2 is a more reliable marker for acute pancreatitis than amylase as its levels rise very quickly in acute pancreatitis patients and remain elevated for days or even weeks, whereas amylase levels start to decline after 1-3 days

BHR Pharmaceuticals Ltd
41, Centenary Business Centre, Hammond Close, Nuneaton, Warwickshire CV11 6RY
: t : +44 (0) 870 0349 606 : : f : +44 (0) 870 0349 607 : : e : info@bhr.co.uk :